Very Low Lead Levels Linked With IQ Deficits, According To NEJM Study
NIH/National Institute Of Environmental Health Sciences
2003-04-17
A new study suggests that lead may be harmful even at very low blood concentrations. The study, funded by the National Institute of Environmental Health Sciences of the National Institutes of Health, will appear in the April 17 edition of The New England Journal of Medicine.
The five-year study found that children who have blood lead concentration lower than 10 micrograms per deciliter suffer intellectual impairment from the exposure. The researchers also discovered that the amount of impairment attributed to lead was most pronounced at lower levels. The study was carried out by researchers from Cornell University, Cincinnati Children's Hospital Medical Center, and the University of Rochester School of Medicine.
An important feature of this new study is its focus on children with blood lead levels below 10 micrograms per deciliter, a threshold currently used by the Centers for Disease Control and Prevention to define an elevated lead level. Previous research has been concerned primarily with lead's effects in the 10 to 30 micrograms per deciliter range, yet the new study finds lead-related impairments at lower levels.
"In this sample of children we find that most of the damage to intellectual functioning occurs at blood lead concentrations that are below 10 micrograms per deciliter," said Richard Canfield, Division of Nutritional Sciences at Cornell University and primary author on the study. The amount of impairment attributed to lead exposure was much greater than the researchers had expected. "We were surprised to find that in our study the IQ scores of children who had blood lead levels of 10 micrograms per deciliter were about 7 points lower than for children with levels of 1 microgram per deciliter," Canfield said.
At the same time, the study found that an increase in blood lead from 10 to 30 micrograms per deciliter is associated with only a small additional decline in IQ. "Because most prior research focused on children with higher exposures than in our sample, we suspected that those investigators could estimate only the amount of additional damage that occurs after blood lead has reached 10 micrograms per deciliter unaware that more damage may occur at lower levels," said Charles Henderson, Department of Human Development at Cornell.
Deborah Cory-Slechta, director of the NIEHS Environmental Health Sciences Center at University of Rochester School of Medicine, said, "Our study also emphasizes the need to understand the behavioral deficits indicated by lower IQ scores."
Before 1970, childhood lead poisoning was defined by a blood lead concentration greater than 60 micrograms per deciliter. Since then, the threshold used to define an elevated blood lead level declined several times, before reaching the current value of 10 micrograms per deciliter. . Under this definition, more than one in every 50 children in the United States between the ages of 1 and 5 years is adversely affected by lead, which has been linked to lowered intelligence, behavioral problems, and diminished school performance. Nearly 1 in 10 young children have a lead level above 5 micrograms per deciliter, according to CDC figures.
"Our study suggests that there is no discernable threshold for the adverse effects of lead exposure and that many more children than previously estimated are affected by this toxin," said Bruce Lanphear, Cincinnati Children's Hospital and director of the hospital's Children's Environmental Health Center. "Despite a dramatic decline over the last two decades in the prevalence of children who have blood lead concentrations above 10 micrograms per deciliter, these data underscore the increasing importance of prevention."
The study followed 172 children in the Rochester, N.Y., area whose blood lead was assessed at 6, 12, 18, 24, 36, 48, and 60 months, and who were tested for IQ at both 3 and 5 years of age. The researchers controlled for many other factors that contribute to a child's intellectual functioning, such as birth weight, mother's intelligence, income, education, and amount of stimulation in the home.
"Any detectable effect occurring from such a widespread exposure is cause for concern," Walter J. Rogan, M.D., said. Rogan is a NIEHS researcher who has studied lead exposure in children but was not an author on the study. "Relatively small changes in the mean IQ of a large number of children will dramatically increase the proportion of children below any fixed level of concern, such as an IQ of 80, and decrease the proportion above any 'gifted' level such as 120," Rogan said.
The authors of the study are Richard L. Canfield and Charles R. Henderson, Jr., Cornell University, Ithaca, N.Y.; Deborah A. Cory-Slechta, University of Rochester School of Medicine, Rochester, N.Y.; Christopher Cox, National Institute of Child Health and Human Development, NIH, DHHS, Bethesda, Md.; Todd A. Jusko, University of Washington, Seattle, Wash.; and Bruce P. Lanphear, Cincinnati Children's Hospital Medical Center. NIEHS funds centers for environmental and children's health at University of Rochester, University of Cincinnati, and University of Washington.
UCLA Imaging Study Reveals How Active Empathy Charges Emotions; Physical Mimicry Of Others Jump-starts Key Brain Activity
University Of California, Los Angeles, Health Sciences
2003-04-08
A child falls from his bicycle and his father winces. A bride says "I do" and the maid of honor grins from ear to ear. A mother frowns with displeasure and her infant son frowns back.
UCLA neuroscientists using functional magnetic resonance imaging (fMRI) are the first to demonstrate that empathetic action, such as mirroring facial expressions, triggers far greater activity in the emotion centers of the brain than mere observation.
Reporting in the April 15 edition of the peer-reviewed Proceedings of the National Academy of Science, the researchers also identified the brain's oval-shaped insula as a key to translating active imitation of others' feelings into meaningful emotion.
The findings explain why humans vary in their ability to understand the pain, joy and anger of others, and how damage to this neural circuit might impair the ability to empathize with the emotions of others, as often seen in patients with autism, a socially isolating psychiatric disease.
"For years scientists have observed the reflexive mimicking of a wince when someone suffers a painful injury, and the infectious nature of joy or anger," said Dr. Marco Iacoboni, a neuroscientist affiliated with the UCLA Neuropsychiatric Institute and the UCLA Brain Research Institute who led the study.
"Our findings show for the first time how these reflexive facial expressions prompt our brain to heighten our empathy for the feelings of others," said Iacoboni, an associate professor-in-residence of psychiatry and biobehavioral sciences at the David Geffen School of Medicine at UCLA. "Understanding the mechanism for regulating empathy explains the continuum of empathy in humans, and also moves us closer toward identifying ways to better control our emotional responses and reverse impairment caused by brain injury, illness and age. This research is especially important for understanding core deficits in autism, such as imitation and empathic resonance."
Using the resources of UCLA's Ahmanson-Lovelace Brain Mapping Center, the researchers evaluated the neural response of 11 research subjects to a series of pictures depicting six emotions -- happiness, sadness, anger, surprise, disgust and fear. The subjects observed the pictures through magnetic-compatible goggles and were asked either to imitate and internally generate the target emotion in the picture, or simply to observe.
The researchers found that imitation and observation of emotions activated a largely similar network of brain activity. Within this network, composed by motor areas as well as the inferior frontal cortex, superior temporal cortex, insula and amygdala, researchers found increased activity during imitation than during observation of emotions. The cortex is the outer layer of the brain.
Previous brain studies from Iacoboni's lab had discovered that the superior temporal and inferior frontal cortices are critical areas for imitation. These areas are connected to the limbic system -- the brain's emotion centers -- via the insula. Therefore, the researchers surmise the insula plays a fundamental role in regulating emotional content, perhaps acting as a critical relay in translating empathetic imitation into emotion.
The study was funded by the Brain Mapping Medical Research Organization, the Brain Mapping Support Foundation, the Pierson-Lovelace Foundation, The Ahmanson Foundation, the Tamkin Foundation, the Jennifer Jones-Simon Foundation, the Capital Group Companies Charitable Foundation, the Robson Family, the Northstar Fund and the National Center for Research Resources.
In addition to Iacoboni, other researchers involved in the study included Laurie Carr, now at Michigan State University, and Marie Charlotte Dubeau of the Ahmanson-Lovelace Brain Mapping Center at the UCLA Neuropsychiatric Institute; Dr. John C. Mazziotta, director of the Ahmanson-Lovelace Brain Mapping Center and professor and chair of neurology at UCLA's David Geffen School of Medicine; and Gian Luigi Lenzi of the Department of Neurological Sciences at the University "La Sapienza," in Rome, Italy.
The UCLA Neuropsychiatric Institute is an interdisciplinary research and education institute devoted to the understanding of complex human behavior, including the genetic, biological, behavioral and sociocultural underpinnings of normal behavior, and the causes and consequences of neuropsychiatric disorders. In addition to conducting fundamental research, the institute faculty seeks to develop effective treatments for neurological and psychiatric disorders, improve access to mental-health services, and shape national health policy regarding neuropsychiatric disorders.
The UCLA Brain Research Institute fosters and improves interdisciplinary collaborations in all aspects of neuroscience, from molecules to the mind, from the laboratory bench to the patient's bedside. This work has increasingly permitted the identification of pathogenic mechanisms and the creation of new therapeutic approaches.
Copyright © 1995-2002 ScienceDaily Magazine
Cocaine Use May Alter Brain Cells, Play Role In Depression
NIH/National Institute On Drug Abuse
2003-03-07
A study by researchers from the University of Michigan and the Ann Arbor Veterans Affairs Medical Center suggests that chronic cocaine use may cause damage to brain cells that help produce feelings of pleasure, which may contribute, in part, to the high rates of depression reported among cocaine abusers. It is well-known that cocaine increases levels of the brain chemical dopamine, resulting in the "high" that abusers feel. Prolonged use of the drug, however, may reduce dopamine levels, making it harder for abusers to experience positive feelings.
Dr. Karley Little, lead investigator, and colleagues studied samples of brain tissue obtained during autopsies of 35 long-term cocaine users and 35 non-users. They analyzed the tissue for dopamine and the protein VMAT2, which is found in dopamine transporters. Urine or serum samples were also analyzed for the presence of cocaine, opioids, antidepressants, and antipsychotic medications. A person close to each individual was interviewed about the individual's substance abuse, alcoholism, and symptoms of personality and mood disorders.
Researchers found that cocaine users had lower concentrations of dopamine and VMAT2 in their brains than did non-users. Additionally, cocaine users suffering from depression had lower levels of VMAT2 than those who were not depressed. Dr. Little and colleagues were uncertain whether dopamine cells had been destroyed or just dysregulated by cocaine use, and if such changes could be reversed.
These findings suggest that chronic cocaine use may cause changes in the brain that could make it harder for a person to feel a sense of pleasure. Further efforts at clarifying the detrimental effects of cocaine on brain cells may help in the development of effective treatment interventions and pharmacotherapies.
This study, funded in part by the National Institute on Drug Abuse, was published in the January 2003 issue of the American Journal of Psychiatry.
|